Endo

Endo International plc is a global specialty pharmaceutical company focused on developing, manufacturing, and distributing branded and generic pharmaceutical products. They generate revenue through the sale of these products, which include pain management, urology, and endocrinology treatments. Founded in 1997, Endo has grown through strategic acquisitions, including the purchase of Paladin Labs and Par Pharmaceutical. Notably, the company has faced legal challenges related to opioid litigation, which is an important aspect of its recent history.

Recent Posts by Endo

1-20 of 26